HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arden Q1

This article was originally published in The Rose Sheet

Executive Summary

Fragrance launches including With Love...Hilary Duff and Danielle by Danielle Steel and skin care products such as a new Prevage anti-aging eye product helped drive a 12.1% increase in revenues to $254.8 mil. in the first quarter (ended Sept. 30), Elizabeth Arden announces Nov. 3. The performance also benefited from the addition of brands from the Rivera Concepts and Sovereign Sales acquisitions (1"The Rose Sheet" July 10, 2006, In Brief and 2"The Rose Sheet" Aug. 21, 2006, In Brief). Britney Spears fragrances grew 14% due to gains from the Fantasy and Midnight Fantasy scents, while the house of Elizabeth Taylor was up 37%, driven by sales of a limited edition White Diamonds perfume. Arden's U.S. mass fragrance business was up 10% in the quarter, and non-Arden department store scents advanced 8%. Arden's net loss in Q1 was $1.31 mil., including restructuring charges, compared to a net gain of $895,000 in the prior-year period...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel